Exai Bio Presents New Multi-Cancer Early Detection Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
Findings in over 3,000 subjects demonstrate highly sensitive and specific detection of multiple cancers at…
Month: June 2023
Affimed Presents AFM24 Monotherapy Data in Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology and Provides Strategic Update on AFM24 Development Plan
Data update from AFM24-101 phase 1/2 monotherapy study includes 15 patients from the EGFR mutant…
Allogene Therapeutics Presents Updated ALLO-501/501A Phase 1 Data in Large B Cell Lymphoma at the American Society of Clinical Oncology (ASCO) Annual Meeting
Long Term Follow Up Data from Phase 1 ALPHA/ALPHA2 Trials Demonstrate Potential of Allogeneic CD19…
Elicio Therapeutics Announces Positive Interim Data from the Phase 1 Study of an Investigational Therapeutic Cancer Immunotherapy, ELI-002, in Patients with High Relapse Risk Pancreatic and Colorectal Cancer at the ASCO Annual Meeting
ELI-002 was shown to be well-tolerated with no dose limiting toxicity or cytokine release syndrome…
Apexigen Announces Phase 2 Data Evaluating Sotigalimab, its CD40 Agonist Antibody, in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma Presented at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
– Marked increases in overall survival observed across soft tissue sarcoma patients – – Demonstrated…
Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
Early on-treatment ctDNA reduction in stable disease patients treated with KIMMTRAK was associated with longer…
Massive Bio and The Oncology Institute (TOI) Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research
NEW YORK–(BUSINESS WIRE)–Massive Bio, a leader in leveraging artificial intelligence and concierge services to empower…
Atlas Global Announces Changes to Canadian Operations
CHATHAM, ONTARIO and TEL-AVIV, ISRAEL, June 02, 2023 (GLOBE NEWSWIRE) — Atlas Global Brands Inc….
loanDepot Makes Executive Changes and Streamlines Organization
Changes in line with Vision 2025 strategy David Hayes named Chief Financial Officer IRVINE, Calif.–(BUSINESS…
loanDepot Makes Executive Changes and Streamlines Organization
Changes in line with Vision 2025 strategy David Hayes named Chief Financial Officer IRVINE, Calif.–(BUSINESS…
Delaware Investments National Municipal Income Fund Announces Revised Fund Adoption Date
PHILADELPHIA–(BUSINESS WIRE)–Today, Delaware Investments National Municipal Income Fund (the “Fund”), a New York Stock Exchange…
Delaware Investments National Municipal Income Fund Announces Revised Fund Adoption Date
PHILADELPHIA–(BUSINESS WIRE)–Today, Delaware Investments National Municipal Income Fund (the “Fund”), a New York Stock Exchange…
Natuzzi S.p.A: First Quarter 2023 Financial Results and Shareholder Letter
First Quarter 2023 Highlights 1Q 2023 Invoiced Sales Amounted to €86.1 Million, a Decrease of…
Natuzzi S.p.A: First Quarter 2023 Financial Results and Shareholder Letter
First Quarter 2023 Highlights 1Q 2023 Invoiced Sales Amounted to €86.1 Million, a Decrease of…
FG Financial Group Announces Closing of Public Offering
ITASCA, Ill.–(BUSINESS WIRE)–FG Financial Group, Inc. (Nasdaq: FGF) (the “Company”), a reinsurance and asset management…
FG Financial Group Announces Closing of Public Offering
ITASCA, Ill.–(BUSINESS WIRE)–FG Financial Group, Inc. (Nasdaq: FGF) (the “Company”), a reinsurance and asset management…
Agra Ventures Announces Upcoming Annual General & Special Meeting
VANCOUVER, British Columbia, June 02, 2023 (GLOBE NEWSWIRE) — Agra Ventures Ltd. (“AGRA” or the…
IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
– Additional data from Phase 1 combination with FOLFIRI continues to show encouraging activity in…
Elicio Therapeutics Reports Inducement Grant to New Chief Financial Officer
BOSTON, June 02, 2023 (GLOBE NEWSWIRE) — Elicio Therapeutics (Nasdaq: ELTX), a clinical-stage biotechnology company…
Certara to Participate in the Jefferies Global Healthcare Conference
PRINCETON, N.J., June 02, 2023 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader…